DIMERIX LIMITED — Interim / Quarterly Report 2012

Feb 26, 2012

Appendix 4D Half yearly report

Rules 4.1, 4.3

Appendix 4D

Half yearly report

Introduced 30/6/2002.

Name of entity

Sun Biomedical Limited

ABN or equivalent company Half yearly Preliminary Half year/financial year ended (‘current period’) reference (tick) final (tick) 18 001 285 230 √ 31 December 2011

Results for announcement to the market

	1.2.12.22.32.42.52.63.4.5.6.7.	CurrentPreviousMovementReporting period31 Dec 2011$ 31 Dec 2010$ %Revenues from ordinary activities6,949312,001(98%)(Loss)/Profit before tax(214,058)23,984N/ANet (loss) / Profit for the period attributable tomembers(214,058)23,984N/ADividends (distributions)Amount perordinary share2011Amount perordinary share2010Interim distribution--Final distribution--Record date for determining entitlement to thefinal distributionN/AN/ADate the final distribution is payableN/AN/ACommentary on Results and Explanatory Information.Refer to the Review of Operations in the Directors Report on page 2.31 Dec 201131 Dec 2010Net tangible assets per security (cents)0.05830.0683Details of entities over which control has beengained or lost during the periodN/AN/ADetails of individual and total dividends ordistributions and dividend or distributionpaymentsN/AN/ADividend reinvestment planN/AN/ADetails of associates and joint venture entitiesNilNil

• See chapter 19 for defined terms.

Appendix 4D Page 1

30/6/2002

Appendix 4D Half yearly report

8.9.	Foreign entities accounting framework – allforeign subsidiaries dormantN/AN/AAudit dispute or qualification.This report is based on accounts which have been reviewed and the review report is attached to the half yearreport attached to this Appendix 4D.

This is a half yearly report, it is to be read in conjunction with the most recent annual financial report.

• See chapter 19 for defined terms.

Appendix 4D Page 2

30/6/2002